Insights from 2023 ASCO® Annual Meeting

 

CNS
21:24

Insights from 2023 ASCO® Annual Meeting

Breaking Bad Barriers: Brain-Penetrant Small Molecule Inhibitors

FEATURING Ardaman Shergill
  • 105 views
  • August 9, 2023
  • 1
06:05

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 INDIGO Study Updates - Vorasidenib vs. Placebo for Residual or Recurrent Grade 2 Glioma With an IDH1/2 Mutation"

FEATURING Matthias Preusser
  • 317 views
  • June 15, 2023
  • 1
04:02

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Phase 3 TRIDENT Study (EF-32) - Tumor Treating Fields Concomitant With CRT and Maintenance TTFields Therapy/Temozolomide in Newly Diagnosed Glioblastoma"

FEATURING Wenyin Shi
  • 109 views
  • June 8, 2023